Histopathological classification and prognostic factors of cancer of the bladder and the upper urinary tract;Classification histopathologique et facteurs pronostiques des cancers de la vessie et des voies excretrices superieures

Oncologie

Volumn 2, Issue 6-7, 2000, Pages 293-302

  Billerey, C ^a   Le Pessot, F ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; BLADDER CANCER; BLADDER PAPILLOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CARCINOMA IN SITU; EMBRYONAL RHABDOMYOSARCOMA; GENETIC DISORDER; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; URINARY TRACT CANCER;

EID: 0033710043     PISSN: 12923818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Muscularis differentiates two populations with different prognosis in stage T1 bladder cancer
2. Urothelial transitional cell carcinoma with endophytic patterns. A discussion of patterns of invasion and problems associated with assessment of invasion in 18 cases
3. Pathology of the urinary bladder and urethra. An update
4. Lymphoepithelioma-like carcinoma of the urinary bladder
5. Chromosome abnormalities and p53 expression in a small cell carcinoma of the bladder
6. Primary peripheral primitive neurectodermal tumor of urinary bladder
7. Small cell carcinoma of the urinary bladder treated with chemotherapy and radiotherapy: Results in five cases
8. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas
9. Etude des variations interpathologistes dans l'evaluation du grade et du stade des tumeurs vesicales. Analyse par 12 pathologistes de 110 tumeurs classees initialement pT1
10. The nested variant of urothelial carcinoma of the urinary b adder. Report of five cases and review of literature
11. A genotype study of the C-HA-RAS-1 locus in human bladder tumors
12. CliniCal evaluation of cell desoxyribonucleic acid content measured by flow cytometry in bladder cancer
13. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
14. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer
15. Natural history of urothelial dysplasia of the bladder
16. p53 et pronostic des tumeurs urotheliales vesicales
17. Comparison of five histopathologic methods to assess cellular proliferation in transitional cell carcinoma of the urinary bladder
18. Carcinosarcomes et carcinomes sarcomatoides. Conceptions actuelles et implications pratiques
19. Altered expression of the retinoblastoma gene product: Prognostic indicator in bladder cancer
20. The nested variant of transitional cell carcinoma: An aggressive neoplasm with innocuous histology
21. The impact of schistosomiasis on the pathology of bladder carcinoma
22. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder
23. Accumulation of p53 and tumor progression in bladder cancer
24. Sarcomatoid carcinoma of the urinary bladder
25. Bladder cancer: Natural history, tumor markers, and early detection strategies
26. Primary adenocarcinoma of the urinary bladder: A clinicopathologic analysis of 72 cases
27. Primary signet-ring cell carcinoma of the urinary bladder
28. Donnees nouvelles dans la classification de tumeurs urotheliales de la vessie
29. Pseudosarcomatous myofibroblastic tumor of the urinary bladder in children: A study of 11 cases with review of the literature. An intergroup rhabdomyosarcoma study
30. Verrucous carcinoma of the bladder
31. The relationship among multiple recurrences, progression, and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years
32. The importance of th depth of invasion in stage T1 bladder cancer: A prospective cohort study
33. Carcinoma in situ of the bladder
34. pT1 urothelial carcinoma of the bladder: Criteria for diagnosis, pitfalls and clinical implications
35. Micropapillary bladder carcinoma: A clinicopathological study of 20 cases
36. Inflammatory pseudotumor of the urinary bladder. A clinicopathological, immuno-histochemical, ultrastructural and flow cytometric study of 13 cases
37. Primary mesenchymal tumors of the urinary bladder. A histological and immunohistochemical study of 30 cases
38. Pathology of transitional cell carcinoma of bladder and its clinical implications
39. The pronostic significance of vascular invasion in stage T1 bladder cancer
40. Prognostic factors in bladder cancer. A pathologic, immunohistochemical, and DNA flow-cytometry study
41. Superficial bladder cancer: The role of molecular marker in the treatment of high-risk superficial disease
42. Micropapillary variant of bladder carcinoma: A case report with p53 gene mutations
43. Usefulness of MiB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: Comparison with Ki-67 antibody
44. Osteoclastoma-like giant tumor of the renal pelvis associated with papillary transitional cell carcinoma
45. World Health Organization. International histological classification of tumours
46. Primary T-cell lymphoma of the urinary bladder
47. Tumors of the kidney, bladder, and related urinary structures
48. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder
49. Human chorionic gonadotropin β-subunit synthesis by undifferentiated urothelial carcinoma with syntitiotrophoblastic differentiation
50. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and cerbB2 in the progresion of invasive bladder cancer
51. Clear cell adenocarcinoma of the urethra: Evidence for origin within paraurethral ducts
52. Two molecular pathways to transitional cell carcinoma of the bladder
53. Prognostic markers in bladder cancer: A contemporary review of the literature
54. Sarcomatoid carcinoma of the urinary bladder. Clinicopathologic analysis of 18 cases with immunohistochemical and electron microscopic findings
55. Primary signet-ring cell carcinoma of the urinary bladder
56. Toward an objective method of mitotic figure counting and its prognostic significance in bladder cancer
57. Image cytometry determination of plouidy level, proliferative activity and nuclear size in a series of 314 transitional bladder cell carcinomas
58. Invasion of the bladder by transitional cell carcinoma. Its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2
59. Chromosome 8p deletion are associated with invasive tumor growth in urinary bladder cancer
60. Inflammatory (mylofibroblastic) pseudotumor of the bladder: A review and differential diagnosis
61. Expression of retinoblastoma gene product and p53 protein in bladder carcinoma: Correlation with Ki67 index
62. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of urinary bladder
63. Transitional cell carcinomas of the urinary bladder that may be underdiagnosed. A report of four invasive cases exemplifying the homology between neoplastic and nonneoplastic transitional cell lesions
64. Microcystic transitional cell carcinomas of the urinary bladder: A report of four cases